107 related articles for article (PubMed ID: 20429838)
1. High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.
York TP; van den Oord EJ; Langston TB; Edmiston JS; McKinney W; Webb BT; Murrelle EL; Zedler BK; Flora JW
Biomarkers; 2010 Jun; 15(4):367-77. PubMed ID: 20429838
[TBL] [Abstract][Full Text] [Related]
2. Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD).
Rana GS; York TP; Edmiston JS; Zedler BK; Pounds JG; Adkins JN; Varnum SM; Smith RD; Liu Z; Li G; Webb BT; Murrelle EL; Flora JW
Anal Bioanal Chem; 2010 Jul; 397(5):1809-19. PubMed ID: 20442989
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking.
Bortner JD; Richie JP; Das A; Liao J; Umstead TM; Stanley A; Stanley BA; Belani CP; El-Bayoumy K
J Proteome Res; 2011 Mar; 10(3):1151-9. PubMed ID: 21186835
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
[TBL] [Abstract][Full Text] [Related]
5. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.
Merkel D; Rist W; Seither P; Weith A; Lenter MC
Proteomics; 2005 Jul; 5(11):2972-80. PubMed ID: 16075419
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
Casado B; Iadarola P; Luisetti M; Kussmann M
Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
[TBL] [Abstract][Full Text] [Related]
7. Improved image analysis workflow for 2-D gels enables large-scale 2-D gel-based proteomics studies--COPD biomarker discovery study.
Bandow JE; Baker JD; Berth M; Painter C; Sepulveda OJ; Clark KA; Kilty I; VanBogelen RA
Proteomics; 2008 Aug; 8(15):3030-41. PubMed ID: 18618493
[TBL] [Abstract][Full Text] [Related]
8. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Chen H; Wang D; Bai C; Wang X
J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
[TBL] [Abstract][Full Text] [Related]
11. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
[TBL] [Abstract][Full Text] [Related]
12. The human plasma proteome: analysis of Chinese serum using shotgun strategy.
He P; He HZ; Dai J; Wang Y; Sheng QH; Zhou LP; Zhang ZS; Sun YL; Liu F; Wang K; Zhang JS; Wang HX; Song ZM; Zhang HR; Zeng R; Zhao X
Proteomics; 2005 Aug; 5(13):3442-53. PubMed ID: 16047309
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 and cyclophilin A associate with the pathogenesis of COPD.
Hu R; Ouyang Q; Dai A; Tan S; Xiao Z; Tang C
Respirology; 2011 Aug; 16(6):983-93. PubMed ID: 21585617
[TBL] [Abstract][Full Text] [Related]
14. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
Kałucka S
Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
Stav D; Raz M
Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
[TBL] [Abstract][Full Text] [Related]
17. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.
Verrills NM; Irwin JA; He XY; Wood LG; Powell H; Simpson JL; McDonald VM; Sim A; Gibson PG
Am J Respir Crit Care Med; 2011 Jun; 183(12):1633-43. PubMed ID: 21471098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
